(Q38176316)

30 August 2017

1 reference

title

The mode of action of interferons in viral infections and their possible role in the control of hepatitis B. (English)

1 reference

30 August 2017

Billiau A

1

1 reference

PubMed ID

2439572

30 August 2017

language of work or name

1 reference

1 January 1986

1 reference

30 August 2017

Journal of Hepatology

1 reference

30 August 2017

3 Suppl 2

1 reference

30 August 2017

S171-9

1 reference

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

30 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Administration of human fibroblast interferon in chronic hepatitis-B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Biochemical pathways in interferon-action

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Interferon-mediated inhibition of virus penetration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Mechanism of Interferon Action: Further Evidence for Transcription as the Primary Site of Action in Simian Virus 40 Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Interferon Action III. The Rate of Primary Transcription of Vesicular Stomatitis Virus is Inhibited by Interferon Action

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Interferon-directed inhibition of chronic murine leukemia virus production in cell cultures: lack of effect on intracellular viral markers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Effect of interferon on exogenous, endogenous, and chronic murine leukemia virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Influence of interferon on virus particle formation in different oncornavirus carrier cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Influence of interferon on virus-particle synthesis in oncornavirus-carrier lines. II. Evidence for a direct effect on particle release

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Trapping of oncornavirus particles at the surface of interferon-treated cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Influence of Input Multiplicity of Infection on the Antiviral Activity of Interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Synthesis and cleavage processing of oncornavirus proteins during interferon inhibition of virus particle release

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Interferon inhibits C-type virus at a posttranscriptional, prerelease step

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Effect of Interferon on Murine Leukaemia Virus Infection. IV. Formation of Non-infectious Virus in Chronically Infected Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Effect of interferon on mouse leukaemia virus (MuLV). V. Abnormal proteins in virions of Rauscher MuLV produced in the presence of interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Effect of Prolonged Interferon Treatment on Mouse Embryonic Fibroblasts Transformed by Murine Sarcoma Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Induction of Alpha Interferon by Membrane Interaction between Viral Surface and Peripheral Blood Mononuclear Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Failure to Demonstrate Circulating Interferon During Incubation Period and Acute Stage of Transfusion-Associated Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Failure to Detect Circulating Interferon During Acute Viral Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Absence of circulating interferon in patients with infectious and serum hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Replication of lactate dehydrogenase-elevating virus in macrophages. 2. Mechanism of persistent infection in mice and cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Circulating interferon in mice infected with the lactate dehydrogenase-elevating virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

Anti-interferon globulin inhibits the development of glomerulonephritis in mice infected at birth with lymphocytic choriomeningitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980117-9

7 January 2021

10.1016/S0168-8278(86)80117-9

Identifiers

DOI

1 reference

30 August 2017

1 reference

PubMed ID

2439572